News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

|Videos|May 4, 2020

In an Instant: The Changing Face of Psychiatry

Author(s)P Priyanka, MD

FaceTime, Skype, and other video chat functions are the new normal in the COVID-19 era, and allow this community psychiatrist serve the underserved.

Medical Director for California-based Community Psychiatry, Dr Priyanka shares her experience with telepsychiatry and discusses the transformation of telemedicine before, during, and (hopefully) after COVID-19. Community Psychiatry is an outpatient psychiatric care company with over 120 clinicians in over 40 locations across California.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Related Content

teen phone bed

No Screens Before Bed: Teen Smartphone Use at Bedtime Predicts Overnight Phone Activity

ByLeah Kuntz,Gina M. Mathew, PhD

June 15th 2026

Maksym/Adobe Stock

Artificial Intelligence in Psychopharmacology: Promise and Pitfalls, With Roy Perlis, MD

ByJoseph F. Goldberg, MD,Roy Perlis, MD

June 10th 2026

“Engineered Addiction”: Redefining Addictive Disorders and the Psychiatric Impact of Social Media

June 8th 2026

AI-Driven Biomarker Discovery from Wearables in Neuropsychiatric Research

ByMark Gerstein, PhD

June 5th 2026

Harm Reduction for Behavioral Addiction in the Digital Age

ByHector A. Colon-Rivera, MD, MBA, MRO, FAPA

May 21st 2026

Latest CME

Southern California Psychiatry Conference

In-Person Event

Southern California Psychiatry Conference

July 10-11, 2026

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Ilan Melnick, MD; Linda Collado, MD, DABPN, FAPA; Maria Collado, MD, FAPA

Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Patricia Junquera, MD; Maria Collado, MD; Erin C. Crown, MHSPAS, PA-C, Psych-CAQ

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Juan D. Oms, MD, FAPA; Linda Collado, MD, DABPN, FAPA; Ginger Shupe, MD

Trending on Psychiatric Times

Podcast: Practical Insights Into the Evolving Treatment of Bipolar Disorder With David Dunner, MD, FACPsych

Preventing Relapse in Schizophrenia: Focus on Women’s Mental Health

Psychiatric Comorbidities in Adults With Congenital Heart Disease and the Need for Interdisciplinary Care

Seltorexant as Adjunctive Therapy for MDD With Insomnia

New Phase 3 Post Hoc Analyses of Centanafadine for the Treatment of Adults With ADHD